ArticleBehavioral sciences (Basel, Switzerland)2025
Treating Young Refugees with a Grief-Focused Group Therapy-A Feasibility Trial.
Article in Behavioral sciences (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The death of a loved one has been identified as one of the most commonly reported traumatic experiences among refugees. This phenomenon can lead to the development of prolonged grief disorder (PGD), for which particularly elevated PGD rates were observed among refugees. Currently, there is no treatment specifically designed for refugees with PGD. Therefore, this study investigates the feasibility of a newly developed grief-focused cognitive behavioral group therapy (G-CBT) for this population. Four young refugees aged 16 to 18 and suffering from PGD were assessed pre, during and after treatment. We found a high comorbidity of PGD, posttraumatic stress disorder (PTSD) and depression at baseline. Among completers, clinician-rated PGD symptom severity decreased clinically significantly at posttreatment and remained stable at the three- and six-month follow-ups. The results indicate good feasibility in an outpatient setting with therapists providing positive feedback. However, larger and controlled studies are needed to prove its efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.